Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Switch Symbol:
Revenue Performance
Above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$9.50M
↑ 101% above average
Average (9y)
$4.73M
Historical baseline
Range
High:$14.70M
Low:$773000.00
CAGR
+15.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $9.50M | +6.2% |
| 2023 | $8.95M | -39.2% |
| 2022 | $14.70M | +277.4% |
| 2021 | $3.90M | +404.0% |
| 2020 | $773000.00 | -47.7% |
| 2019 | $1.48M | +4.4% |
| 2018 | $1.42M | -21.0% |
| 2017 | $1.79M | -20.4% |
| 2016 | $2.25M | -11.1% |
| 2015 | $2.53M | - |